Merck KGaA
page
1
of
1
Merck KGaA sees bright future after solid results
Nov 15, 2012 07:49 EST
German chemicals and pharmaceuticals group Merck KGaA said on Thursday it was raising its sales forecasts for this year after posting solid figures for the third quarter.
Merck KGaA suffers setback for cancer drug
Sep 18, 2012 12:03 EDT
German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer.
Merck KGaA to axe 1,100 jobs in Germany by end 2015
Sep 04, 2012 05:44 EDT
German chemicals and pharmaceuticals group Merck KGaA said Tuesday it will cut one job out of every 10 in Germany over the next three years as part of a global cost-cutting drive.
Merck KGaA suffers setback on cancer drug
Jul 05, 2012 06:28 EDT
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Pharma firm Merck slashes jobs in Switzerland
Apr 24, 2012 06:56 EDT
The struggling German pharmaceuticals group Merck KGaA said Tuesday it would close the headquarters of a subsidiary in Geneva, cutting 580 Swiss jobs and redeploying 750 others.
Special Report: A prescription for corruption
Feb 28, 2012 07:10 EST
BELGRADE (Reuters) - According to a signal from the electronic tag around his ankle, Nenad Borojevic last left his apartment building at 6.25 p.m. on January 10. It was the festive season in Serbia; the capital was enjoying the lull between Orthodox Christmas and New Year.
BASF buys electrolytes business from rival Merck
Feb 21, 2012 06:31 EST
BASF, the world's biggest chemicals maker, said Tuesday it has agreed to buy the electrolytes business for high-performance batteries from rival Merck KGaA for an undisclosed sum.
EU agency issues guideline on biosimilar MS drugs
Jan 20, 2012 06:35 EST
LONDON (Reuters) - European regulators took another step towards opening the market for copies of biotech drugs on Friday by releasing a draft guideline on how companies should test biosimilar medicines containing interferon beta, used to treat multiple sclerosis.
Three European companies douse hopes for new drugs
Dec 20, 2011 05:24 EST
LONDON/PARIS (Reuters) - Three of Europe's biggest drugmakers -- AstraZeneca <AZN.L>, Novartis <NOVN.VX> and Sanofi <SASY.PA> -- reported product setbacks on Tuesday, underlining the difficulties of developing new medicines to make up for those going off patent.
Facebook sidelines contested Merck profile page
Nov 28, 2011 23:10 EST
Facebook will sideline a Merck page at the social network until a pair of US and German companies work out which one gets the online address, a source familiar with the matter told AFP.
Facebook apologizes for Merck homepage mix-up
Nov 28, 2011 17:42 EST
(Reuters) - Facebook Inc said on Monday that it made a mistake in letting Merck & Co take over a page on the social networking website from its German rival Merck KGaA.
Facebook apologizes for Merck homepage mix-up
Nov 28, 2011 16:53 EST
(Reuters) - Facebook Inc said on Monday that it made a mistake in letting Merck & Co take over a page on the social networking website from its German rival Merck KGaA.
Facebook apologizes for Merck homepage mix-up
Nov 28, 2011 16:33 EST
(Reuters) - Facebook Inc said on Monday that it made a mistake in letting Merck & Co <MRK.N> take over a page on the social networking website from its German rival Merck KGaA <MRCG.DE>.
Facebook apologizes for Merck homepage mix-up
Nov 28, 2011 15:22 EST
(Reuters) - Facebook Inc said on Monday that it made a mistake in letting Merck & Co <MRK.N> take over a page on the social networking website from its German rival Merck KGaA <MRCG.DE>.
Merck said to hijack German rival's Facebook page
Nov 23, 2011 16:42 EST
(Reuters) - German drugmaker Merck KGaA accused U.S. rival Merck & Co of hijacking its Facebook page and said it plans to sue to get it back.
Merck said to hijack German rival's Facebook page
Nov 23, 2011 10:53 EST
(Reuters) - German drugmaker Merck KGaA accused U.S. rival Merck & Co of hijacking its Facebook page and said it plans to sue to get it back.
Merck said to hijack German rival's Facebook page
Nov 23, 2011 10:37 EST
(Reuters) - German drugmaker Merck KGaA accused U.S. rival Merck & Co of hijacking its Facebook page and said it plans to sue to get it back.
Merck said to hijack German rival's Facebook page
Nov 23, 2011 10:31 EST
(Reuters) - German drugmaker Merck KGaA accused U.S. rival Merck & Co of hijacking its Facebook page and said it plans to sue to get it back.
Merck fined $950 mn over painkiller marketing
Nov 23, 2011 02:46 EST
Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for wrongfully marketing its former hit painkiller Vioxx, the US Department of Justice said.
Merck KGaA tones down sales forecast due to LCD outlook
Oct 26, 2011 02:31 EDT
DARMSTADT, Germany (Reuters) - German drugs and chemicals group Merck KGaA has cut the top end of its sales forecast for 2011 by 2 percent after sluggish demand for consumer electronics dimmed the prospects for its liquid crystals unit.
Facts from the Wikipedia page:
  | |
| Type | Public KGaA (FWB: MRK) |
|---|---|
| Founded | 1668 |
| Founder(s) | Friedrich Jacob Merck |
| Headquarters | Darmstadt, Germany |
| Key people | Karl-Ludwig Kley (CEO and Chairman of the executive board), Wilhelm Simson (Chairman of the supervisory board) |
| Industry | Chemicals, pharmaceuticals |
| Products | Liquid crystals, life science and performance chemicals, over-the-counter medicines, small molecules and biopharmaceuticals |
| Revenue | €7.558 billion (2008)[1] |
| Operating income | ▲ €731 million (2008)[1] |
| Profit | ▲ €367.1 million (2008)[1] |
| Employees | 32,800 (2008)[1] |
| Subsidiaries | Merck Serono |
| Website | www.merck.de |
